Linagliptin and secoisolariciresinol diglucoside attenuate hyperlipidemia and cardiac hypertrophy induced by a high-methionine diet in rats via suppression of hyperhomocysteinemia-induced endoplasmic reticulum stress

• Auteurs principaux: Israa A. Jalal (Auteur), Abeer Elkhoely (Auteur), Shimaa K. Mohamed (Auteur), Amany A. E. Ahmed (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2023-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: Cardiac hypertrophy (CH) is one of the contributing causes of morbidity and mortality. Hyperhomocysteinemia (HHcy) is one of the diseases which may predispose hyperlipidemia and CH. Linagliptin (Lina) and secoisolariciresinol diglucoside (SDG) are known to alleviate a variety of illnesse...